Von Willebrand factor and the thrombophilia of severe COVID-19: in situ evidence from autopsies
Description
CONCLUSION: We provide in situ evidence of VWF-rich thrombi, likely attributable to COVID-19, and suggest that VWF may be a therapeutic target in severe COVID-19.
